Jeff Fensterer, Vice President of Marketing Strategy at Animated Dynamics, Inc., introduces an under-development biodynamic imaging platform for bladder cancer. The assay could have clinical utility in selecting patients for neoadjuvant chemotherapy, as well as treatment planning.
In this video, Fensterer discloses the thesis of the discussion he led during the 2018 Future Directions in Urology Symposium (FDUS).
